BEAT-IT: Comparing a behavioural activation treatment for depression in adults with intellectual disabilities with an attention control: study protocol for a randomised controlled trial
- PMID: 26714891
- PMCID: PMC4696180
- DOI: 10.1186/s13063-015-1103-5
BEAT-IT: Comparing a behavioural activation treatment for depression in adults with intellectual disabilities with an attention control: study protocol for a randomised controlled trial
Abstract
Background: Depression appears to be more enduring amongst people with intellectual disabilities, suggesting that it is a more chronic problem or more poorly managed in this population. This is not helped by a lack of evidence about the effectiveness of psychological therapies for people who have intellectual disabilities and depression. Behavioural activation, which aims to counteract depression by increasing individuals' level of meaningful activity and their exposure to positive reinforcers, has proven to be as effective as cognitive behavioural therapy in the general population. Given that this therapy makes fewer communicative demands and focuses on activity, it was thought that behavioural activation would be both accessible and apt for people with intellectual disabilities, who are often socially marginalised.
Methods/design: This study is a multi-centre single-blind randomised controlled trial of behavioural activation versus a self-help attention control intervention for depression in adults with mild/moderate intellectual disabilities. The study has an internal pilot in one centre, to establish that recruitment can be built up and sustained at the required level, before being rolled out across the other sites. One hundred sixty-six participants will be randomly assigned to the behavioural activation or self-help interventions, which will be delivered to individuals with mild to moderate intellectual disabilities, accompanied by someone who provides them with regular support. Both interventions are manualised and will be delivered over a period of approximately 4 months. The primary outcome measure will be the Glasgow Depression Scale, a self-report measure which is completed at baseline and 4 and 12 months post-randomisation. Secondary outcomes include measures of participants' activity levels, proxy reports of depressive symptoms, and cost-effectiveness.
Discussion: The study will provide evidence about the effectiveness of behavioural activation for depression, adapted for people who have mild/moderate intellectual disabilities, and will inform the delivery of psychological therapies to people with intellectual disabilities in practice.
Trial registration: Date trial registered: Nov. 13, 2012; trial registration number: ISRCTN 09753005.
Similar articles
-
Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial.Lancet Psychiatry. 2017 Dec;4(12):909-919. doi: 10.1016/S2215-0366(17)30426-1. Epub 2017 Nov 16. Lancet Psychiatry. 2017. PMID: 29153873 Free PMC article. Clinical Trial.
-
Cognitive behaviour therapy (CBT) for anxiety and depression in adults with mild intellectual disabilities (ID): a pilot randomised controlled trial.Trials. 2011 Apr 14;12:95. doi: 10.1186/1745-6215-12-95. Trials. 2011. PMID: 21492437 Free PMC article. Clinical Trial.
-
Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT.Health Technol Assess. 2018 Sep;22(53):1-130. doi: 10.3310/hta22530. Health Technol Assess. 2018. PMID: 30265239 Free PMC article. Clinical Trial.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
The utility of behavioral activation therapy in addressing emotional problems of two depressed students with borderline intellectual disability: A case study.Brain Behav. 2024 Aug;14(8):e3651. doi: 10.1002/brb3.3651. Brain Behav. 2024. PMID: 39192702 Free PMC article.
-
Effect of Cognitive Behavioral Intervention Combined with the Resilience Model to Decrease Depression and Anxiety Symptoms and Increase the Quality of Life in ESRD Patients Treated with Hemodialysis.Int J Environ Res Public Health. 2023 May 28;20(11):5981. doi: 10.3390/ijerph20115981. Int J Environ Res Public Health. 2023. PMID: 37297585 Free PMC article. Clinical Trial.
-
Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial.Lancet Psychiatry. 2017 Dec;4(12):909-919. doi: 10.1016/S2215-0366(17)30426-1. Epub 2017 Nov 16. Lancet Psychiatry. 2017. PMID: 29153873 Free PMC article. Clinical Trial.
-
Behavioural activation therapy for depression in adults with non-communicable diseases.Cochrane Database Syst Rev. 2020 Aug 6;8(8):CD013461. doi: 10.1002/14651858.CD013461.pub2. Cochrane Database Syst Rev. 2020. PMID: 32841367 Free PMC article.
-
Development of a supported self-management intervention for adults with type 2 diabetes and a learning disability.Pilot Feasibility Stud. 2018 May 29;4:106. doi: 10.1186/s40814-018-0291-7. eCollection 2018. Pilot Feasibility Stud. 2018. PMID: 29862037 Free PMC article.
References
-
- Morris JK. The National Down Syndrome Cytogenetic Register 2007/8 Annual Report. Barts and The London School of Medicine and Dentistry. London: Queen Mary University of London; 2009.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical